The possibility that four loci (REN, THO, PARP, SOD2) are associated with longevity was explored by comparing the genotypic pools of subjects older than 100 years with those of younger subjects matched for sex and geographic area (northern and southern Italy). The markers (all located within the respective gene) were HUMREN4; HUMTHO1; HUMPARP (gt)845nt; SOD2(C/T)401nt. In order to reduce the number of genotypes, multiallelic polymorphisms were recoded as diallelic according to allele size and frequency patterns (small: S, and large: L, alleles). A significant loss of LL homozygous genotypes was found at the THO locus in male but not in female centenarians with respect to matched controls. On the other hand no significant difference was found between case/control genotypic frequencies at REN, PARP, SOD2 loci. The latter loci therefore do not affect inter-individual variability in life expectancy (at least in terms of qualitative variants associated with the tested markers). However, the data is consistent with an association between the THO locus and longevity.

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.ejhg.5200222DOI Listing

Publication Analysis

Top Keywords

parp sod2
12
loci ren
8
ren tho
8
tho parp
8
tho locus
8
gene/longevity association
4
association studies
4
studies autosomal
4
loci
4
autosomal loci
4

Similar Publications

Despite the increasing understanding of the pathogenesis of glioblastoma (GBM), treatment options for this tumor remain limited. Recently, the therapeutic potential of natural compounds has attracted great interest. Thus, dietary flavonoids quercetin (QCT) and kaempferol (KMF) were investigated as potential cytostatic agents in GBM.

View Article and Find Full Text PDF

Age-related macular degeneration (AMD), a leading cause of blindness, is characterized by mitochondrial dysfunction of retinal pigment epithelium (RPE) cells. EUK-134 is a mimetic of SOD2 and catalase, widely used for its antioxidant properties in models of light-induced damage or oxidative stress. However, its effects on the retina are not yet clear.

View Article and Find Full Text PDF
Article Synopsis
  • Se-methylselenocysteine (MSC) shows promise for preventing cancer, particularly in a type of lung cancer called non-small cell lung cancer (NSCLC).
  • In tests, MSC slowed down cancer cell growth, reduced their ability to move and invade, and made them die more often.
  • The research also found that MSC worked by affecting certain pathways in the cells and showed it could shrink tumors in mice, making it a possible treatment for NSCLC.
View Article and Find Full Text PDF
Article Synopsis
  • Osteosarcoma is a type of bone cancer that mostly affects kids and teens, and researchers are testing a drug called benzamil to see if it can help treat it.
  • In the study, two types of osteosarcoma cells were treated with benzamil and several tests were done to measure cell growth and death.
  • The results showed that benzamil made the cancer cells die by reducing certain proteins that help the cells survive and affecting their energy production.
View Article and Find Full Text PDF

In this study, we evaluated IL-15 stimulated natural killer cell-derived EVs (NK-EVs) as therapeutic agents in vitro and in vivo in Osimertinib-resistant lung cancer (H1975R) with EGFR mutations (L858R) in combination with carboplatin (CBP). NK-EVs were isolated by ultracentrifugation and characterized by nanoparticle tracking analysis, and atomic force microscopy imaging revealed vesicles with a spherical form and sizes meeting the criteria of exosomal EVs. Further, Western blot studies demonstrated the presence of regular EV markers along with specific NK markers (perforin and granzyme).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!